Impact of concomitant carcinoma in situ distribution on non‐muscle‐invasive bladder cancer progression risk
Papillary NMIBC progression risk varies with concomitant CIS distribution. Only multifocal concomitant CIS is a risk factor for progression in patients with T1 NMIBC. If validated in further studies, risk calculators should consider including this CIS distinction. Submitting separate specimens at the time of transurethral resection, as recommended by guidelines, should be encouraged.
Authors
- Frank Papanikolaou
- Amna Ali (ORCID: https://orcid.org/0000-0001-5745-2743)
- Neil Fleshner (ORCID: https://orcid.org/0000-0001-7407-7463)
- Jason Y. Lee
- Kellie Kim (ORCID: https://orcid.org/0000-0003-4682-6409)
- Andrew Feifer (ORCID: https://orcid.org/0000-0003-0530-2246)
- Girish S. Kulkarni (ORCID: https://orcid.org/0000-0002-6929-6124)
- Kenneth T. Pace (ORCID: https://orcid.org/0000-0003-2778-6675)
- Nathan Perlis (ORCID: https://orcid.org/0000-0003-1258-9847)
- Amy Chan
- Zizo Al‐Daqqaq
- Theodorus van der Kwast (ORCID: https://orcid.org/0000-0001-8640-5786)
- Jethro C.C. Kwong (ORCID: https://orcid.org/0000-0003-4728-1025)
- Katherine Lajkosz (ORCID: https://orcid.org/0000-0003-3760-5401)
- Marian S. Wettstein (ORCID: https://orcid.org/0000-0003-1378-3625)
- Robert J. Hamilton (ORCID: https://orcid.org/0000-0002-6715-5934)
- Maximiliano Ringa
- Antonio Finelli (ORCID: https://orcid.org/0000-0003-4032-6120)
- Yashan Chelliahpillai
- Soomin Lee (ORCID: https://orcid.org/0000-0002-0518-3534)
- Alexandre R. Zlotta
- Thomas Short
- Munir Jamal
Institutions
- Mount Sinai Hospital (CA)
- University Health Network (CA)
- University of Toronto (CA)
- Trillium Health Centre (CA)
- Health First (US)
- Sinai Health System (CA)
- Orano (United States) (US)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1111/bju.16793
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01